We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sinusitis in Children and the Nasopharyngeal Microbiome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01492868
Recruitment Status : Active, not recruiting
First Posted : December 15, 2011
Last Update Posted : March 3, 2017
Sponsor:
Collaborators:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The purpose of this study is to investigate the relationship between viral infections of the upper respiratory tract, perturbations of the nasopharyngeal microbiome in children, and the risk of acute bacterial sinusitis over a one year period. The investigators will determine the incidence of acute bacterial sinusitis post viral upper respiratory infection and identify the viral antecedent infections and other risk factors which predispose to infection and ultimately design strategies to reduce the burden of disease and antimicrobial resistance.

Condition or disease
Sinusitis

Study Design

Study Type : Observational
Estimated Enrollment : 355 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Sinusitis in Children and the Nasopharyngeal Microbiome
Study Start Date : January 2012
Estimated Primary Completion Date : June 2017
Estimated Study Completion Date : December 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Sinusitis
U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Primary Outcome Measures :
  1. Incidence of acute bacterial sinusitis in children 49 to 84 months of age (which is the peak age incidence of sinusitis) as a complication of an antecedent viral upper respiratory infection. [ Time Frame: Over a 1 year time frame ]

Secondary Outcome Measures :
  1. Define relationships between the nasopharyngeal microbiome, viral illnesses, and progression to clinical sinusitis. [ Time Frame: Over a 1 year time frame ]

Biospecimen Retention:   Samples Without DNA
Nasopharyngeal microbiome samples

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   4 Years to 7 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Healthy children
Criteria

Inclusion Criteria:

  • Children 4 to 7 years of age
  • Healthy
  • English-speaking parent/guardian -

Exclusion Criteria:

  • Any underlying condition which would predispose them to the development of sinusitis including congenital or acquired immunodeficiencies
  • Craniofacial abnormalities
  • Cystic fibrosis
  • Allergic rhinitis or a previous episode of chronic sinusitis.
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01492868


Locations
United States, Wisconsin
UW Pediatrics at 20 S. Park St
Madison, Wisconsin, United States, 53715
UW Health West Towne Pediatrics
Madison, Wisconsin, United States, 53717
Sponsors and Collaborators
University of Wisconsin, Madison
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Investigators
Principal Investigator: Ellen R Wald, MD University of Wisconsin, Madison
More Information

Additional Information:
Responsible Party: University of Wisconsin, Madison
ClinicalTrials.gov Identifier: NCT01492868     History of Changes
Other Study ID Numbers: GRANT 10785179
1R01AI097172-01 ( U.S. NIH Grant/Contract )
First Posted: December 15, 2011    Key Record Dates
Last Update Posted: March 3, 2017
Last Verified: March 2017

Keywords provided by University of Wisconsin, Madison:
sinusitis
upper respiratory infection

Additional relevant MeSH terms:
Sinusitis
Paranasal Sinus Diseases
Nose Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Otorhinolaryngologic Diseases